We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
29 Aug 2020 - 02 Sep 2020
Virtual Venue

Minimally Invasive Solution Alleviates Chronic Tendinosis

By HospiMedica International staff writers
Posted on 11 Apr 2016
Print article
Image: The Tenex Health TX system console (Photo courtesy of Tenex Health).
Image: The Tenex Health TX system console (Photo courtesy of Tenex Health).
An innovative disposable surgical instrument uses targeted ultrasonic energy to address tendinosis of the shoulder and hip by removing soft tissue.

The Tenex Health TX system is designed to execute percutaneous tenotomy in patients who suffer from soft tissue tendon pain. Following administration of a local anesthetic, gentle ultrasonic energy is used to safely breakdown and remove the damaged tissue via a MicroTip, which requires only a micro-incision to reach the damaged tissue. Because the incision is so small and the ultrasonic energy precisely treats only damaged tendon tissue, surrounding healthy tissue is left unharmed, and patients enjoy faster recovery times when compared to traditional open surgical procedures.

The system is controlled by the proprietary Tenex Health TX console, a portable, self-contained device that includes a one-step, easy-load tubing set and a quick, one-touch prime cycle. Simple touchscreen controls lead the operator through a treatment interface, with computer-guided programming instructions and at-a-glance parameter and user settings. The interface also includes smart safety features and a single-use, preassembled handpiece system to hold a disposable TX MicroTip.

Two MicroTips are available, the TX1 and TX2, with the TX2 being an extended length version of the TX1 that allows physicians to complete the procedure in regions of the body not typically accessible by the shorter instrument. The most common problem is some soreness after the procedure, which can be treated with over-the-counter (OTC) pain medication, and typically lasts for a short period of time. The TX system is a product of Tenex Health (Lake Forest, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The TX1 MicroTip has enjoyed tremendous clinical success in treating over 35,000 patients in the US since its introduction in 2012,” said Bernard Morrey, MD, chief medical officer of Tenex Health. “Only a small portion have been treated with shoulder or hip tendinosis, due to the inaccessibility of the deeper tissues to the TX1 MicroTip. The length and design of the TX2 MicroTip is well poised to effectively treat a large number of patients with a spectrum of conditions in these anatomic areas.”

“The TX System using the TX1 MicroTip has been used by physicians for the past few years and demonstrated to be effective in treating chronic tendinosis in a variety of body parts. The longer needle associated with the TX2 product will provide physicians the needed technology to definitively treat chronic tendinosis in the shoulder and hip,” said James Andrews, MD, of the Andrews Institute (Gulf Breeze, FL, USA). “Soft tissue injuries in both of these body parts are well suited to be treated through a minimally invasive approach using the TX2 product.”

Related Links:

Tenex Health

Print article



view channel

Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio

Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.